RFQ
Menu
Merck

Merck, SML0803-25MG, VUF10661

Size:25 mg, (3S)-N-[(1S)-5-Amino-1-[[(2, 2-diphenylethyl)amino]carbonyl]pentyl]-2-(1, 4-dioxo-4-phenylbutyl)-1, 2, 3, 4-tetrahydro-3-isoquinolinecarboxamide, ≥98% (HPLC)
Available Catalog Numbers
SML0803-25MGSML0803-5MG
Catalog Number: SML0803-25MG
Pricing

Send a RFQ.

View RFQ List
Category
Size Exclusion Resins
Pack Size25 mg
CollectionsMerck Cell Culture Supplements & Reagents: Complete Solutions for Research & BioproductionMerck Roche Life Science Products for PCR, RT‑PCR & Nucleic Acid Purification
Manufacturer's Pagewww.sigmaaldrich.com/US/en/product/SIGMA/SML0803
Description
Biochem/physiol Actions
VUF10661 is a potent agonist of the chemokine receptor CXCR3.
VUF10661 is a potent agonist of the chemokine receptor CXCR3. VUF10661 induces receptor internalization, recruitment of ?-arrestins and activates Gi proteins with similar potency to endogenous CXCL ligands.
Features and Benefits
This compound is featured on the Chemokine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
Specifications

General

UNSPSC Code51111800
Web Name Suffix Override≥98% (HPLC), Chemokine receptor CXCR3 agonist, powder
NACRESNA.77
assay≥98% (HPLC)
formpowder
colorwhite to beige
solubilityDMSO: 10 mg/mL, clear
storage temp.−20°C
Quality Level100
Merck SML0803-25MG VUF10661 | IRIGHT